The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25497216 |
99 |
Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model. |
Boehringer Ingelheim Pharma |
| 18096386 |
131 |
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis. |
Bristol-Myers Squibb |
| 19620010 |
43 |
Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists. |
Astellas Pharma |
| 17418570 |
141 |
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
| 15771462 |
125 |
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. |
Pharmaceutical Research Institute |
| 15713390 |
53 |
The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists. |
Schering-Plough Research Institute |
| 11311066 |
76 |
Design, synthesis, and discovery of a novel CCR1 antagonist. |
Banyu Tsukuba Research Institute In Collaboration With Merck Research Laboratories |
Search and Browse
